About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Kidswell Bio Corporation(4584) Financial Results

4584
TSE Growth
Kidswell Bio Corporation
103
JPY
-1
(-0.96%)
Dec 23, 3:30 pm JST
0.65
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 996 -969 -991 -1,001 -34.8 0 May 13, 2021 J-GAAP
Mar, 2022 1,569 -919 -952 -535 -17.4 0 May 12, 2022 J-GAAP
Mar, 2023 2,776 -550 -624 -657 -20.8 0 May 12, 2023 J-GAAP
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 Guidance 4,000 -1,000 -1,000 -950 -23.4 0 Nov 12, 2024 J-GAAP
YoY +64.5% +25.1% +28.0% +33.2% +41.9%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 2,776 -316 -88 -89 -17.4
Fiscal Year Mar, 2023 Mar, 2012 Mar, 2008 Mar, 2008 Mar, 2022
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 829 -469 -489 -72 -2.3 0 May 12, 2022 J-GAAP
Oct - Mar, 2022 1,660 -561 -582 -615 -19.4 0 May 12, 2023 J-GAAP
Oct - Mar, 2023 1,850 -616 -645 -642 -18.2 0 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 2,251 -738 -733 -709 -17.4 0 Nov 12, 2024 J-GAAP
YoY +21.7% -19.8% -13.6% -10.4% +4.0%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 -919 -643 -1,169 526 369 1,187 33.89 J-GAAP
Mar, 2023 -550 -1,449 -1,421 -28 1,356 1,067 27.40 J-GAAP
Mar, 2024 -1,335 -453 1,617 2,231 43.87 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 1,116 11 -42 -42 -1.4 Nov 8, 2022 J-GAAP
Apr - Sep, 2023 581 -719 -744 -780 -24.1 Nov 8, 2023 J-GAAP
Apr - Sep, 2024 1,749 -262 -267 -241 -6.1 Nov 12, 2024 J-GAAP
YoY +201.0% +63.6% +64.1% +69.1% +74.7%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 610 -146 -152 -152 -4.8 -23.9 Feb 7, 2023 J-GAAP
Jan - Mar, 2023 1,050 -415 -430 -463 -14.6 -39.5 May 12, 2023 J-GAAP
Apr - Jun, 2023 45 -455 -470 -470 -14.7 -1,011.1 Aug 7, 2023 J-GAAP
Jul - Sep, 2023 536 -264 -274 -310 -9.6 -49.3 Nov 8, 2023 J-GAAP
Oct - Dec, 2023 985 52 32 33 1.0 5.3 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 865 -668 -677 -675 -19.1 -77.2 May 14, 2024 J-GAAP
Apr - Jun, 2024 482 -158 -176 -176 -4.5 -32.8 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 1,267 -104 -91 -65 -1.6 -8.2 Nov 12, 2024 J-GAAP
YoY +136.4% +60.6% +66.8% +79.0% +82.9%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 1,267 52 59 369 12.1
Fiscal Year Sep, 2024 Dec, 2023 Jun, 2015 Dec, 2021 Dec, 2021
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 48.79 43.8 3,503 1,533 -10,613 0.46 May 12, 2022 J-GAAP
Mar, 2023 32.36 26.6 3,894 1,037 -11,287 1.88 May 12, 2023 J-GAAP
Mar, 2024 21.35 13.2 5,085 669 -12,709 3.85 May 14, 2024 J-GAAP
Apr - Sep, 2024 16.6 4,645 773 -12,950 2.76 Nov 12, 2024 J-GAAP